AI assistant
Sending…
Arcus Biosciences, Inc. — Director's Dealing 2020
Aug 5, 2020
31966_dirs_2020-08-04_198a72a4-8fdf-4f8b-9838-5cd3942e3c94.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Arcus Biosciences, Inc. (RCUS)
CIK: 0001724521
Period of Report: 2020-07-31
Reporting Person: Grossman William (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-07-31 | Common Stock | P | 100 | $19.77 | Acquired | 500 | Direct |
| 2020-07-31 | Common Stock | P | 100 | $19.6756 | Acquired | 600 | Direct |
More from Arcus Biosciences, Inc.
Regulatory Filings
2026
Apr 20
Board/Management Information
2026
Mar 23
Capital/Financing Update
2026
Feb 25
Annual Report
2026
Feb 25
Earnings Release
2026
Feb 25
Director's Dealing
2026
Jan 26
Director's Dealing
2026
Jan 26
Director's Dealing
2026
Jan 26
Director's Dealing
2026
Jan 26
Director's Dealing
2026
Jan 26